Skip to main content

Risperidone (Form 1)

Therapy Area
Bipolar Disorder/Anti-Schizophrenic
API Technology
Synthetic
Formulation
Oral Solids
Injectable
Liquid
Development Status
Available
Available Regulatory Filing
USA
Canada
CEP
Europe
Japan
Korea
Brazil
Innovator Brand (US)
RISPERDAL

We are here to help, if you have any country specific requirements - please Contact Us.